Logiscreen

Bausch Health Companies Inc

$5.37
Market Cap 1.99B
ROE 122.6%
Gross Margin 70.8%
Debt/Equity -10.1
Current Ratio 1.3
Revenue QoQ 11.7%
EPS QoQ 22.9%
F-Score 2

About

Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global diversified pharmaceutical company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals and eye health, through our approximately 88.7% ownership of Bausch + Lomb. With our leading durable brands, we are delivering on our commitments as we build an innovative company dedicated to advancing global health.

Exchange
NYSE
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-1.61
vs median 31.50
P/B
-0.95
vs median 2.17
ROE
1.23
vs median 0.09

Lower quality - review fundamentals carefully

Small-cap company with higher volatility

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics